US 11291658
Use of gaboxadol in the treatment of diabetes and related conditions
granted A61KA61K31/155A61K31/437
Quick answer
US patent 11291658 (Use of gaboxadol in the treatment of diabetes and related conditions) held by OVID THERAPEUTICS INC. expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/155, A61K31/437, A61K31/4985, A61K45/06